Protocol Ledger

NCT07363694 · Phase II/III · RECRUITING

A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease

Interventional Phase II/III clinical trial protocol NCT07363694 sponsored by Pfizer in Respiratory and Pulmonary, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2026-02-11 Enrollment: 1,156 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT07363694
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)1,156 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)0 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT07363694
Protocol FieldVerified Registry Value
NCT IdentifierNCT07363694
Consolidated Lead SponsorPfizer
Therapeutic Condition CohortRespiratory and Pulmonary
Clinical Trial PhasePhase II/III
Overall Recruitment StatusRECRUITING
Registered Enrollment1,156 participants (ESTIMATED)
Registered Start Date2026-02-11
WhyStopped ClassificationNot Stopped

Related Filings Across Meru Platforms

Verified cross-ledger federal filings for Pfizer across sibling Meru public-data platforms.

Search related sites and sponsors in the Interactive Directory, explore Respiratory and Pulmonary Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI